Abiopharma

News bot Jan. 29, 2026, 8:08 p.m.

📋 Bristol-Myers Squibb Co. (BMYMP) - Clinical Trial Update

Filing Date: 2026-01-12

Accepted: 2026-01-12 10:20:51

Event Type: Clinical Trial Update

Event Details:

Bristol-Myers Squibb Co. (BMYMP) Announces Clinical Trial Update Bristol-Myers Squibb Co. (BMYMP) provided an update on its clinical development programs. Clinical Development Highlights:

Drug Program: pricing, Built
Diseases/Conditions: our products, Growth 44th Annual J
Clinical Stage: clinical trial
Update Type: Trial Timeline Adjustment
Primary Factors: Regulatory Process
Collaboration: Bristol Myers Squibb
- expected in 2026
- targeting CAR T RRMM Golcadomide 1L FL (GOLSEEK-2) MYK-224 HFpEF (AURORA) Pumitamig Solid Tumors2 Zola-cel Autoimmune Diseases (Breakfree-1 & 2) 2027
- Targeting BCMAxGPRC5D CAR T ª RR Multiple Myeloma HbF Activating CELMoD ª Sickle Cell Disease BMS-9864

🔬 Clinical Development Pipeline (Bristol-Myers Squibb Co.):

Product	Type	Development Stage	Therapeutic Area	Source
Yervoy	DRUG	Preclinical	Melanoma	ClinicalTrials.gov
Drugs Nivolumab	DRUG	Phase PHASE2	Renal Cell Carcinoma, Clear Cell	ClinicalTrials.gov
Relatlimab plus Nivolumab	DRUG	Phase PHASE2	Basal Cell Carcinoma	ClinicalTrials.gov
Standard of Care Surgery	PROCEDURE	Phase PHASE2	Head and Neck Cancer	ClinicalTrials.gov
Current standard of care treatment options	DRUG	Preclinical	Systemic Lupus Erythematosus (SLE)	ClinicalTrials.gov
Nivolumab + Relatlimab	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Aromatase Inhibition Therapy	DRUG	Approved	Anatomic Stage I Breast Cancer AJCC v8	ClinicalTrials.gov
BMS-986460	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986482	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
BMS-986488	DRUG	Phase PHASE1	Advanced Malignant Tumors	ClinicalTrials.gov
BMS-986500	DRUG	Phase PHASE1	Advanced Solid Tumor	ClinicalTrials.gov
BMS-986506	DRUG	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
BMS-986517	DRUG	Phase PHASE1	Solid Tumours	ClinicalTrials.gov
BMS-986523	DRUG	Phase PHASE1	Advanced Solid Malignancies	ClinicalTrials.gov
BMS-986454	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-986435	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Etoposide	DRUG	Phase PHASE3	Extensive-Stage Small Cell Lung Cancer	ClinicalTrials.gov
Carboplatin	DRUG	Phase PHASE3	Extensive-Stage Small Cell Lung Cancer	ClinicalTrials.gov
Atezolizumab	BIOLOGICAL	Phase PHASE3	Extensive-Stage Small Cell Lung Cancer	ClinicalTrials.gov
BMS-986489 (BMS-986012+Nivolumab)	BIOLOGICAL	Phase PHASE3	Extensive-Stage Small Cell Lung Cancer	ClinicalTrials.gov
Gemcitabine	DRUG	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Capecitabine	DRUG	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Paclitaxel	DRUG	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Nab-paclitaxel	DRUG	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Iza-bren	DRUG	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
KarXT + KarX-EC Matching Placebo	DRUG	Phase PHASE3	Irritability Associated With Autism Spectrum Disorder	ClinicalTrials.gov
KarX-EC	DRUG	Phase PHASE3	Irritability Associated With Autism Spectrum Disorder	ClinicalTrials.gov
KarXT	DRUG	Phase PHASE3	Irritability Associated With Autism Spectrum Disorder	ClinicalTrials.gov
Placebo	DRUG	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Xanomeline Enteric Capsule	DRUG	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Xanomeline/Trospium Chloride Capsule	DRUG	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Survey Administration	OTHER	Approved	Anatomic Stage I Breast Cancer AJCC v8	ClinicalTrials.gov
Discussion	OTHER	Approved	Anatomic Stage I Breast Cancer AJCC v8	ClinicalTrials.gov
Acupuncture Therapy	DEVICE	Approved	Anatomic Stage I Breast Cancer AJCC v8	ClinicalTrials.gov
Acupressure Therapy	PROCEDURE	Approved	Anatomic Stage I Breast Cancer AJCC v8	ClinicalTrials.gov
Ustekinumab	DRUG	Phase PHASE3	Plaque Psoriasis	ClinicalTrials.gov
Deucravacitinib	DRUG	Phase PHASE3	Plaque Psoriasis	ClinicalTrials.gov
Placebo for BMS-986326	OTHER	Phase PHASE1	Lupus	ClinicalTrials.gov
BMS-986326	DRUG	Phase PHASE1	Lupus	ClinicalTrials.gov
Nivolumab	DRUG	Phase PHASE2	Primary Central Nervous System Lymphoma (PCNSL)	ClinicalTrials.gov
Mavacamten	DRUG	Preclinical	Hypertrophic Cardiomyopathy	ClinicalTrials.gov
Omeprazole	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Flurbiprofen	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Bupropion	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Rosuvastatin	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Digoxin	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Metformin	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Repotrectinib	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Durvalumab	DRUG	Phase PHASE3	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Pumitamig	DRUG	Phase PHASE3	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Pembrolizumab	DRUG	Phase PHASE3	Non-Small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Ipilimumab	DRUG	Phase PHASE2	Head and Neck Cancer	ClinicalTrials.gov
prednisone	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
rucaparib	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
enzalutamide	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
docetaxel	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
BMS-986504	DRUG	Phase PHASE2	Pancreatic Ductal Adenocarcinoma	ClinicalTrials.gov
Androgen Deprivation Therapy	DRUG	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
External Beam Radiation Therapy	RADIATION	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Brachytherapy	RADIATION	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Ipilimumab - 3 mg/kg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Nivolumab - 1 mg/kg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
External Beam RT	RADIATION	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Nivolumab - 3 mg/kg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Nivolumab - 480 mg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Ipilimumab - 1 mg/kg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Nivolumab - 240 mg	DRUG	Phase PHASE2	Meningiomas	ClinicalTrials.gov
Cisplatin	DRUG	Phase PHASE2	Urothelial Cancer	ClinicalTrials.gov
Darbeopoetin	DRUG	Phase PHASE2	MDS (Myelodysplastic Syndrome)	ClinicalTrials.gov
Luspatercept	DRUG	Phase PHASE2	MDS (Myelodysplastic Syndrome)	ClinicalTrials.gov
Pemetrexed	DRUG	Phase PHASE2	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Nivolumab + ipilimumab	DRUG	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Platinum Doublet	DRUG	Phase PHASE2	Resectable Stage IIA to IIIB Non-small Cell Lung Cancer	ClinicalTrials.gov
(8gy x 3)	RADIATION	Phase PHASE2	Resectable Stage IIA to IIIB Non-small Cell Lung Cancer	ClinicalTrials.gov
Fulvestrant	DRUG	Phase PHASE1	Advanced Solid Tumor	ClinicalTrials.gov
Palbociclib	DRUG	Phase PHASE1	Advanced Solid Tumor	ClinicalTrials.gov
Cyclophosphamide	DRUG	Phase PHASE1	Childhood Solid Tumor	ClinicalTrials.gov
Vinblastine	DRUG	Phase PHASE1	Childhood Solid Tumor	ClinicalTrials.gov
Elotuzumab	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Radiation Therapy	RADIATION	Phase PHASE2	Oropharynx Squamous Cell Carcinoma	ClinicalTrials.gov
Lamotrigine	DRUG	Phase PHASE3	Bipolar Disorder Type I With Mania	ClinicalTrials.gov
Valproate	DRUG	Phase PHASE3	Bipolar Disorder Type I With Mania	ClinicalTrials.gov
Lithium	DRUG	Phase PHASE3	Bipolar Disorder Type I With Mania	ClinicalTrials.gov
xanomeline and trospium chloride (X/T) therapy	DRUG	Preclinical	Schizophrenia	ClinicalTrials.gov
Lisocabtagene maraleucel	BIOLOGICAL	Preclinical	Non-Hodgkin Lymphoma	ClinicalTrials.gov
Idecabtagene vicleucel	BIOLOGICAL	Preclinical	Non-Hodgkin Lymphoma	ClinicalTrials.gov
Healthy Horizons	BEHAVIORAL	Approved	Rheumatoid Arthritis (RA	ClinicalTrials.gov
Peer Coach	BEHAVIORAL	Approved	Rheumatoid Arthritis (RA	ClinicalTrials.gov
Dexamethasone	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Bortezomib	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Pomalidomide	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
CXCR1/2 Inhibitor SX-682	DRUG	Phase PHASE1	Metastatic Colon Adenocarcinoma	ClinicalTrials.gov
Questionnaire Administration	OTHER	Preclinical	Caregiver	ClinicalTrials.gov
Quality-of-Life Assessment	OTHER	Preclinical	Caregiver	ClinicalTrials.gov
Interview	OTHER	Preclinical	Caregiver	ClinicalTrials.gov
Prescribed treatments for myelodysplastic syndromes (MDS)	DRUG	Preclinical	Myelodysplastic Syndromes (MDS)	ClinicalTrials.gov
Bevacizumab	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Nivolumab/relatlimab/rHuPH20	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Nivolumab and rHuPH20	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Xanomeline/trospium chloride	DRUG	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
Cabozantinib	DRUG	Phase PHASE2	Papillary Renal Cell Carcinoma	ClinicalTrials.gov
Ipilimumab placebo	OTHER	Phase PHASE3	Renal Cell Carcinoma	ClinicalTrials.gov
Dasatinib (BMS-354825)	DRUG	Phase PHASE2	Leukemia	ClinicalTrials.gov
Bone marrow aspiration	PROCEDURE	Phase PHASE1	Highly Sensitized Prospective Kidney Transplant Recipients	ClinicalTrials.gov
belatacept	BIOLOGICAL	Phase PHASE1	Highly Sensitized Prospective Kidney Transplant Recipients	ClinicalTrials.gov
daratumumab	BIOLOGICAL	Phase PHASE1	Highly Sensitized Prospective Kidney Transplant Recipients	ClinicalTrials.gov
Regorafenib	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
BMS-986288	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Corticosteroids	DRUG	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
Enteric Coated Mycophenolate Sodium	DRUG	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
Mycophenolate Mofetil	DRUG	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
Cyclosporine A	DRUG	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
Tacrolimus	DRUG	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
Milvexian	DRUG	Phase PHASE3	Acute Coronary Syndrome	ClinicalTrials.gov
Administration of a combination of treatments	DRUG	Phase PHASE2	Relapsed or Refractory Multiple Myeloma (RRMM)	ClinicalTrials.gov
Lenalidomide	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Carfilzomib	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Apixaban Placebo	DRUG	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
Apixaban	DRUG	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
Mezigdomide	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Teclistamab	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
CC-486	DRUG	Phase PHASE1	AML	ClinicalTrials.gov
Venetoclax	DRUG	Phase PHASE1	AML	ClinicalTrials.gov
Osimertinib	DRUG	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
BMS-986507	DRUG	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
Non-Interventional Study	OTHER	Preclinical	Lung Non-Small Cell Carcinoma	ClinicalTrials.gov
Cetuximab	DRUG	Phase PHASE2	Esophageal Squamous Cell Carcinoma	ClinicalTrials.gov
5-FU	DRUG	Phase PHASE2	Esophageal Squamous Cell Carcinoma	ClinicalTrials.gov
Mosunetuzumab	DRUG	Phase PHASE1	Relapsed/Refractory Non-Hodgkin Lymphoma	ClinicalTrials.gov
Glofitamab/Obinutuzumab	DRUG	Phase PHASE1	Relapsed/Refractory Non-Hodgkin Lymphoma	ClinicalTrials.gov
Rituximab	DRUG	Phase PHASE1	Relapsed/Refractory Non-Hodgkin Lymphoma	ClinicalTrials.gov
BMS-986458	DRUG	Phase PHASE1	Relapsed/Refractory Non-Hodgkin Lymphoma	ClinicalTrials.gov
Immunotherapy	DRUG	Preclinical	Cancer	ClinicalTrials.gov
Admilparant	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Sunitinib	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Oxaliplatin	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Fluorouracil	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Leucovorin	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Regorafinib	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Temozolomide	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Relatlimab	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Trametinib	DRUG	Phase PHASE2	Cancer	ClinicalTrials.gov
Iberdomide	DRUG	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
CAPOX	DRUG	Phase PHASE2	Untreated, Unresectable, or Metastatic Colorectal Cancer	ClinicalTrials.gov
FOLFIRI	DRUG	Phase PHASE2	Untreated, Unresectable, or Metastatic Colorectal Cancer	ClinicalTrials.gov
FOLFOX	DRUG	Phase PHASE2	Untreated, Unresectable, or Metastatic Colorectal Cancer	ClinicalTrials.gov
BMS-986453	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Onureg	DRUG	Phase PHASE1	Hepatic Insufficiency	ClinicalTrials.gov
Nivolumab + Relatlimab Fixed Dose Combination	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
Nivolumab+Ipilimumab	DRUG	Phase PHASE2	Squamous Cell Carcinoma of the Head and Neck	ClinicalTrials.gov
Nivolumab+Relatlimab	DRUG	Phase PHASE2	Squamous Cell Carcinoma of the Head and Neck	ClinicalTrials.gov
BMS-986489	DRUG	Phase PHASE2	Limited Stage Small Cell Lung Cancer	ClinicalTrials.gov
BMS-986525	DRUG	Phase PHASE1	Relapsed/Refractory Small Cell Lung Cancer	ClinicalTrials.gov
mFOLFIRINOX	DRUG	Phase PHASE2	Phase 2 Study	ClinicalTrials.gov
Nivolumab + platinum-based chemotherapy	DRUG	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Cohort D: KTX-1001+ pomalidomide (Pomalyst, Imnovid)	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Cohort C1 & C2: KTX-1001 + Carfilzomib (KYPROLIS®)	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Cohort B1 & B2: KTX-1001+Mezigdomide	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Cohort A1 & A2: KTX-1001	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
BMS-985521	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Sirolimus	DRUG	Phase PHASE1	Graft-versus-host-disease	ClinicalTrials.gov
BMS-986004	DRUG	Phase PHASE1	Graft-versus-host-disease	ClinicalTrials.gov
Sacituzumab Govitecan (SG)	DRUG	Phase PHASE1	Metastatic Triple-negative Breast Cancer	ClinicalTrials.gov
Relatlimab FDC + Nivolumab	DRUG	Phase PHASE1	Metastatic Triple-negative Breast Cancer	ClinicalTrials.gov
Samples collection: Serum	OTHER	Approved	CNS Metastases	ClinicalTrials.gov
Brain MRI	OTHER	Approved	CNS Metastases	ClinicalTrials.gov
Samples collection: Non-CNS Metastatic Tumour Tissue	OTHER	Approved	CNS Metastases	ClinicalTrials.gov
Samples collection: CSF	OTHER	Approved	CNS Metastases	ClinicalTrials.gov
Samples collection: Plasma	OTHER	Approved	CNS Metastases	ClinicalTrials.gov
Vinorelbine	DRUG	Phase PHASE3	Non Small Cell Lung Cancer	ClinicalTrials.gov
Stereotactic Radiosurgery	RADIATION	Phase PHASE1	Chordoma	ClinicalTrials.gov
Laboratory Biomarker Analysis	OTHER	Phase PHASE1	Chordoma	ClinicalTrials.gov
BMS-986213	BIOLOGICAL	Phase PHASE1	Neoplasms by Site	ClinicalTrials.gov
Famotidine	DRUG	Phase PHASE1	Anemia, Sickle Cell	ClinicalTrials.gov
BMS-986470	DRUG	Phase PHASE1	Anemia, Sickle Cell	ClinicalTrials.gov
mFOLFOX6	DRUG	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
KarXT Matching Placebo	OTHER	Phase PHASE3	Schizophrenia	ClinicalTrials.gov
SBRT	RADIATION	Phase PHASE2	Non Small Cell Lung Cancer	ClinicalTrials.gov
Sorafenib	DRUG	Phase PHASE1	Hepatocellular Carcinoma	ClinicalTrials.gov
Enasidenib	DRUG	Phase PHASE2	T-cell Lymphoma	ClinicalTrials.gov
Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination	DRUG	Phase PHASE2	Merkel Cell Carcinoma	ClinicalTrials.gov
Trospium Chloride	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-936558-01	DRUG	Phase PHASE1	Cervical Cancer	ClinicalTrials.gov
BMS-986340	DRUG	Phase PHASE1	Cervical Cancer	ClinicalTrials.gov
Ozanimod	DRUG	Phase PHASE2	Colitis, Ulcerative	ClinicalTrials.gov
CC-99282	DRUG	Phase PHASE2	Follicular Lymphoma	ClinicalTrials.gov
Obinutuzumab	DRUG	Phase PHASE2	Follicular Lymphoma	ClinicalTrials.gov
BMS-986490	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Cytoreductive surgery	PROCEDURE	Phase PHASE1	High Grade Serous Ovarian	ClinicalTrials.gov
Carboplatin and Paclitaxel	DRUG	Phase PHASE1	High Grade Serous Ovarian	ClinicalTrials.gov
BMS-986278 Placebo	DRUG	Phase PHASE3	Progressive Pulmonary Fibrosis	ClinicalTrials.gov
BMS-986278	DRUG	Phase PHASE3	Progressive Pulmonary Fibrosis	ClinicalTrials.gov
BMS-986315	BIOLOGICAL	Phase PHASE1	Advanced Solid Tumor	ClinicalTrials.gov
Relatlimab and nivolumab fixed dose combination (FDC)	DRUG	Phase PHASE2	Stage II Melanoma	ClinicalTrials.gov
Duvelisib	DRUG	Phase PHASE1	Unresectable Melanoma	ClinicalTrials.gov
ctDNA blood test	PROCEDURE	Phase PHASE2	Non Small Cell Lung Cancer	ClinicalTrials.gov
Fedratinib Pill	DRUG	Phase PHASE2	Myeloproliferative Neoplasm	ClinicalTrials.gov
Adoptive Cell Therapy with TIL	BIOLOGICAL	Approved	Metastatic Melanoma	ClinicalTrials.gov
High Dose IL-2	DRUG	Approved	Metastatic Melanoma	ClinicalTrials.gov
Fludarabine as Part of Lymphodepletion	DRUG	Approved	Metastatic Melanoma	ClinicalTrials.gov
Cyclophosphamide as Part of Lymphodepletion	DRUG	Approved	Metastatic Melanoma	ClinicalTrials.gov
Administration of Lymphodepletion	DRUG	Approved	Metastatic Melanoma	ClinicalTrials.gov
Tumor Infiltrating Lymphocytes (TIL)	PROCEDURE	Approved	Metastatic Melanoma	ClinicalTrials.gov
Albumin-Bound Paclitaxel	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Nivolumab Injection [Opdivo]	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
TST001	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Adagrasib	DRUG	Phase PHASE1	Advanced Malignant Tumors	ClinicalTrials.gov
Sacituzumab govitecan	DRUG	Phase PHASE1	Metastatic Urothelial Carcinoma	ClinicalTrials.gov
HuMax-IL8	DRUG	Phase PHASE2	Head and Neck Squamous Cell Carcinoma	ClinicalTrials.gov
Pembrolizumab 200 mg	DRUG	Phase PHASE2	Cutaneous Melanoma	ClinicalTrials.gov
Ipilimumab 1mg/kg and nivolumab 3mg/kg	DRUG	Phase PHASE2	Cutaneous Melanoma	ClinicalTrials.gov
Nivolumab 480mg and relatlimab 160mg	DRUG	Phase PHASE2	Cutaneous Melanoma	ClinicalTrials.gov
Ipilimumab 1mg/kg Nivolumab 480mg and relatlimab 160mg	DRUG	Phase PHASE2	Cutaneous Melanoma	ClinicalTrials.gov
Ipilimumab 3mg/kg and nivolumab 1mg/kg	DRUG	Phase PHASE2	Cutaneous Melanoma	ClinicalTrials.gov
Onureg + Venetoclax	DRUG	Phase PHASE1	Untreated Myelodysplastic Syndrome	ClinicalTrials.gov
Salvage therapy	OTHER	Phase PHASE2	Melanoma Stage Iv	ClinicalTrials.gov
Stereotactic Radiotherapy	RADIATION	Phase PHASE2	Melanoma Stage Iv	ClinicalTrials.gov
Chlorhexidine baths	DRUG	Approved	Bacterial Colonization	ClinicalTrials.gov
Mupirocin	DRUG	Approved	Bacterial Colonization	ClinicalTrials.gov
Azathioprine	DRUG	Preclinical	Ulcerative Colitis (UC)	ClinicalTrials.gov
MRTX1719	DRUG	Phase PHASE1	Mesothelioma	ClinicalTrials.gov
Epoetin Alfa	BIOLOGICAL	Phase PHASE3	Myelodysplastic Syndromes	ClinicalTrials.gov
Approved Non-small Cell Lung Cancer (NSCLC) therapies	DRUG	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Red blood cell transfusion	PROCEDURE	Preclinical	Lower-risk Myelodysplastic Syndromes	ClinicalTrials.gov
Qualitative interviews	OTHER	Preclinical	Myelodysplastic Syndrome (MDS)	ClinicalTrials.gov
Health-related quality of life questionnaires	OTHER	Preclinical	Myelodysplastic Syndrome (MDS)	ClinicalTrials.gov
Corticosteroid	DRUG	Phase PHASE2	Heart Transplantation	ClinicalTrials.gov
GVAX	DRUG	Phase PHASE1	Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)	ClinicalTrials.gov
CCR2/CCR5 dual antagonist	DRUG	Phase PHASE1	Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)	ClinicalTrials.gov
Stereotactic Body Radiation (SBRT)	RADIATION	Phase PHASE1	Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)	ClinicalTrials.gov
BMS-986253	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
Urelumab	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
GVAX pancreatic cancer	BIOLOGICAL	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
KRAS peptide vaccine	DRUG	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
BMS-986322	DRUG	Phase PHASE2	Psoriasis	ClinicalTrials.gov
Crizotinib	DRUG	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
dacarbazine	DRUG	Phase PHASE1	Hodgkin Lymphoma	ClinicalTrials.gov
Bleomycin	DRUG	Phase PHASE1	Hodgkin Lymphoma	ClinicalTrials.gov
doxorubicin	DRUG	Phase PHASE1	Hodgkin Lymphoma	ClinicalTrials.gov
BMS-986249	BIOLOGICAL	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Moxifloxacin Matching Placebo	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Moxifloxacin	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986419 Matching Placebo	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986419	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Peripheral blood collection	PROCEDURE	Phase PHASE1	Metastatic Hormone Refractory Prostate Cancer	ClinicalTrials.gov
Abiraterone acetate	DRUG	Phase PHASE1	Metastatic Hormone Refractory Prostate Cancer	ClinicalTrials.gov
rHuPH20	DRUG	Phase PHASE1	Neoplasms by Site	ClinicalTrials.gov
Oral Azacitidine	DRUG	Phase PHASE1	T-Cell Large Granular Lymphocyte Leukemia	ClinicalTrials.gov
TG4010	BIOLOGICAL	Phase PHASE2	Recurrent Non-Small Cell Lung Carcinoma	ClinicalTrials.gov
Abatacept	DRUG	Phase PHASE2	Interstitial Lung Disease	ClinicalTrials.gov
Non-mavacamten symptomatic oHCM therapy	DRUG	Preclinical	Obstructive Hypertrophic Cardiomyopathy	ClinicalTrials.gov
BMS-986016	DRUG	Phase PHASE2	Microsatellite Unstable Colorectal Cancer	ClinicalTrials.gov
Cobimetinib	DRUG	Phase PHASE2	Microsatellite Unstable Colorectal Cancer	ClinicalTrials.gov
SURGE	BEHAVIORAL	Approved	Gastrointestinal Cancer	ClinicalTrials.gov
Post Treatment Surgery	PROCEDURE	Phase PHASE1	Osteosarcoma	ClinicalTrials.gov
Azacitidine	DRUG	Phase PHASE1	Osteosarcoma	ClinicalTrials.gov
BMS-986213 (Relatlimab-Nivolumab FDC)	DRUG	Phase PHASE2	Renal Cell Carcinoma, Clear Cell	ClinicalTrials.gov
BMS-986497	DRUG	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
NG350A (Cohort C)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Gemcitabine (gem) (Cohort A, B and C)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Nab-paclitaxel (nP) (Cohort A, B and C)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Hydroxychloroquine (HCQ) (Cohort B)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Ipilimumab (Cohort A, B and C)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Nivolumab (Cohort A)	DRUG	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
Obexelimab	DRUG	Phase PHASE3	IgG4 Related Disease	ClinicalTrials.gov
Lirilumab	BIOLOGICAL	Phase PHASE1	Non-Hodgkin's Lymphoma	ClinicalTrials.gov
BMS-986463	DRUG	Phase PHASE1	High-grade Serous Ovarian Carcinoma (HGSOC)	ClinicalTrials.gov
Calcium folinate	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
BMS-986484	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Fedratinib	DRUG	Phase PHASE1	Primary Myelofibrosis	ClinicalTrials.gov
Standard of Care Craniotomy	PROCEDURE	Phase EARLY_PHASE1	Metastatic Melanoma	ClinicalTrials.gov
BMS-986165	DRUG	Phase PHASE3	Psoriasis	ClinicalTrials.gov
Topotecan	DRUG	Phase PHASE2	Neoplasms, Ovarian	ClinicalTrials.gov
Pegylated Liposomal Doxorubicin (PLD)	DRUG	Phase PHASE2	Neoplasms, Ovarian	ClinicalTrials.gov
MORAb-202	DRUG	Phase PHASE2	Neoplasms, Ovarian	ClinicalTrials.gov
Other dual-immuno-oncology therapy with chemotherapy	BIOLOGICAL	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Immuno-oncology-based therapy (excluding nivolumab-based regimens) with chemotherapy	BIOLOGICAL	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Nivolumab + ipilimumab + platinum-based chemotherapy	BIOLOGICAL	Preclinical	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
BMS- 986205	DRUG	Phase PHASE2	Endometrial Adenocarcinoma	ClinicalTrials.gov
Nurse Navigator	OTHER	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Community Resource Specialist	OTHER	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Resource sheets	OTHER	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Niraparib + Ipilimumab	DRUG	Phase PHASE1	Pancreatic Adenocarcinoma	ClinicalTrials.gov
Niraparib + Nivolumab	DRUG	Phase PHASE1	Pancreatic Adenocarcinoma	ClinicalTrials.gov
Irinotecan	DRUG	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
5-fluorouracil (5-FU)	DRUG	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
BMS-813160	DRUG	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
CC-122	DRUG	Phase PHASE1	Non-Hodgkin Lymphoma	ClinicalTrials.gov
BMS-986012	BIOLOGICAL	Phase PHASE2	Extensive-stage Small Cell Lung Cancer	ClinicalTrials.gov
Lecanemab 10 mg/kg	DRUG	Phase PHASE2	Alzheimers Disease	ClinicalTrials.gov
X/T + X-EC	DRUG	Phase PHASE2	Alzheimers Disease	ClinicalTrials.gov
Placebo for Oral Azacitidine	DRUG	Phase PHASE2	Myelodysplastic Syndromes	ClinicalTrials.gov
Data collection	OTHER	Preclinical	Malignant Pleural Mesothelioma	ClinicalTrials.gov
Romidepsin	DRUG	Phase PHASE1	Triple-Negative Breast Cancer	ClinicalTrials.gov
Tazemetostat	DRUG	Phase PHASE1	Atypical Teratoid Rhabdoid Tumor	ClinicalTrials.gov
Rabeprazole	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Platinum-doublet chemotherapy	BIOLOGICAL	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
BMS-986408	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Correlation of body composition PGA and step count with outcomes	OTHER	Preclinical	Geriatric Assessment	ClinicalTrials.gov
Practical Geriatric Assessment	OTHER	Preclinical	Geriatric Assessment	ClinicalTrials.gov
Association of Nivolumab + Relatlimab	DRUG	Phase PHASE2	Soft Tissue Sarcoma Adult	ClinicalTrials.gov
Methotrexate	DRUG	Phase PHASE2	GVHD	ClinicalTrials.gov
Ipilimumab Injection	DRUG	Phase PHASE1	Melanoma (Skin)	ClinicalTrials.gov
Cryotherapy	PROCEDURE	Phase PHASE1	Melanoma (Skin)	ClinicalTrials.gov
Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]	DRUG	Phase PHASE1	Melanoma (Skin)	ClinicalTrials.gov
Surgery	PROCEDURE	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
Losartan	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
FOLFIRINOX	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
Loratadine	DRUG	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Acetaminophen	DRUG	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
BMS-986446 SC	DRUG	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
BMS-986446 IV	DRUG	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Positron Emission Tomography	PROCEDURE	Phase PHASE1	B-Cell Non-Hodgkin Lymphoma-Recurrent	ClinicalTrials.gov
Golcadomide	DRUG	Phase PHASE1	B-Cell Non-Hodgkin Lymphoma-Recurrent	ClinicalTrials.gov
Computed Tomography	PROCEDURE	Phase PHASE1	B-Cell Non-Hodgkin Lymphoma-Recurrent	ClinicalTrials.gov
Biospecimen Collection	PROCEDURE	Phase PHASE1	B-Cell Non-Hodgkin Lymphoma-Recurrent	ClinicalTrials.gov
Biopsy	PROCEDURE	Phase PHASE1	B-Cell Non-Hodgkin Lymphoma-Recurrent	ClinicalTrials.gov
Neoadjuvant relatlimab	DRUG	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Neoadjuvant ipilimumab	DRUG	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Neoadjuvant nivolumab	DRUG	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Placebo matching deucravacitinib	OTHER	Phase PHASE3	Plaque Psoriasis	ClinicalTrials.gov
Post-infusion radiation	RADIATION	Phase PHASE1	DLBCL - Diffuse Large B Cell Lymphoma	ClinicalTrials.gov
Liso-cel	BIOLOGICAL	Phase PHASE1	DLBCL - Diffuse Large B Cell Lymphoma	ClinicalTrials.gov
Bridging radiation therapy	RADIATION	Phase PHASE1	DLBCL - Diffuse Large B Cell Lymphoma	ClinicalTrials.gov
CC-95251	DRUG	Phase PHASE1	Leukemia, Myeloid, Acute	ClinicalTrials.gov
Placebo in combination with nivolumab	DRUG	Phase PHASE3	Unresectable or Metastatic Melanoma	ClinicalTrials.gov
HBI-8000 in combination with nivolumab	DRUG	Phase PHASE3	Unresectable or Metastatic Melanoma	ClinicalTrials.gov
Stereotactic Body Radiation Therapy (SBRT)	RADIATION	Phase PHASE2	Merkel Cell Carcinoma	ClinicalTrials.gov
FLEX Stretching and Toning Program	BEHAVIORAL	Approved	Multiple Sclerosis	ClinicalTrials.gov
Guidelines for Exercise in Multiple Sclerosis (GEMS)	BEHAVIORAL	Approved	Multiple Sclerosis	ClinicalTrials.gov
Neoantigen Dendritic Cell Vaccine	BIOLOGICAL	Phase PHASE2	Hepatocellular Carcinoma	ClinicalTrials.gov
Megestrol acetate	DRUG	Phase PHASE2	Anorexia	ClinicalTrials.gov
Irbesartan	DRUG	Phase PHASE4	Chronic Heart Failure	ClinicalTrials.gov
Didanosine	DRUG	Approved	HIV Infections	ClinicalTrials.gov
stavudine	DRUG	Phase PHASE4	HIV	ClinicalTrials.gov
once daily minimum 3-drug regimen of anti-retroviral medications	DRUG	Phase PHASE4	HIV Infection	ClinicalTrials.gov
Aripiprazole	DRUG	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
Nystatin	DRUG	Approved	Candidiasis, Oral	ClinicalTrials.gov
Observation	PROCEDURE	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
UFT/LV	PROCEDURE	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
Lobucavir	DRUG	Approved	Cytomegalovirus Infections	ClinicalTrials.gov
gp160 Vaccine (MicroGeneSys)	BIOLOGICAL	Phase PHASE1	HIV Infections	ClinicalTrials.gov
HIVAC-1e	BIOLOGICAL	Phase PHASE1	HIV Infections	ClinicalTrials.gov
Smallpox Vaccine	BIOLOGICAL	Phase PHASE1	HIV Infections	ClinicalTrials.gov
Irbesartan treatment	DRUG	Phase PHASE3	Type 2 Diabetes	ClinicalTrials.gov
Intrapartum Cefoxitin (2g) vs. placebo	DRUG	Approved	Puerperal Sepsis	ClinicalTrials.gov
Amphotericin B	DRUG	Approved	Candidiasis, Esophageal	ClinicalTrials.gov
4 FEC 100 followed by 4 Taxol	PROCEDURE	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
6 FEC 100	PROCEDURE	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
Zidovudine	DRUG	Approved	HIV Infections	ClinicalTrials.gov
Lamivudine	DRUG	Approved	HIV Infections	ClinicalTrials.gov
Indinavir sulfate	DRUG	Approved	HIV Infections	ClinicalTrials.gov
UFT (Tegafur/Uracil)	DRUG	Phase PHASE2	Esophageal Neoplasm	ClinicalTrials.gov
Smoking cessation	BEHAVIORAL	Phase PHASE4	Peripheral Arterial Disease	ClinicalTrials.gov
Increase in physical activity	BEHAVIORAL	Phase PHASE4	Peripheral Arterial Disease	ClinicalTrials.gov
Dietary recommendations	BEHAVIORAL	Phase PHASE4	Peripheral Arterial Disease	ClinicalTrials.gov
Stepwise therapy for dyslipidemia, hypertension and diabetes	DRUG	Phase PHASE4	Peripheral Arterial Disease	ClinicalTrials.gov
Sorivudine	DRUG	Phase PHASE3	HIV Infections	ClinicalTrials.gov
ibipinabant	DRUG	Phase PHASE2	Obesity and Type 2 Diabetes	ClinicalTrials.gov
carboplatin, 5FU, Taxol and radiation	DRUG	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
vitamin E	DRUG	Phase PHASE4	Chronic Kidney Disease	ClinicalTrials.gov
pravastatin	DRUG	Phase PHASE4	Chronic Kidney Disease	ClinicalTrials.gov
Chemotherapy	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Entecavir	DRUG	Preclinical	Hepatitis B	ClinicalTrials.gov
Erlotinib	DRUG	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
Dasatinib	DRUG	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
Brivanib	DRUG	Phase PHASE3	Carcinoma, Hepatocellular	ClinicalTrials.gov
Low dose Adjunctive Aripiprazole	DRUG	Phase PHASE3	Bipolar Disorder	ClinicalTrials.gov
warfarin	DRUG	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
rivaroxaban	DRUG	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
dabigatran	DRUG	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
Adalimumab	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Subcutaneous Abatacept	BIOLOGICAL	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Ipilimumab and Fotemustine	DRUG	Phase PHASE2	Metastatic Malignant Melanoma	ClinicalTrials.gov
Telaprevir	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Daclatasvir	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Ribavirin	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Peginterferon Alfa-2a	BIOLOGICAL	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Peginterferon Lambda-1a	BIOLOGICAL	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Sofosbuvir	DRUG	Preclinical	Chronic Hepatitis C	ClinicalTrials.gov
Daclatasvir (BMS-790052)	DRUG	Preclinical	Chronic Hepatitis C	ClinicalTrials.gov
Enoxaparin	DRUG	Phase PHASE3	Venous Thrombosis	ClinicalTrials.gov
Peginterferon alpha-2a	DRUG	Phase PHASE2	Hepatitis C Infection	ClinicalTrials.gov
[11C]BMT-136088	DRUG	Phase PHASE1	Immunology	ClinicalTrials.gov
BMS-986020	DRUG	Phase PHASE1	Immunology	ClinicalTrials.gov
Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC)	DRUG	Phase PHASE1	HIV Infections	ClinicalTrials.gov
IV Abatacept	DRUG	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Placebo matching with Duloxetine	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
Duloxetine	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
BMS-820836	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
Placebo matching with BMS-820836	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
Bevacizumab Placebo (saline solution)	DRUG	Phase PHASE2	Colorectal Cancer (CRC)	ClinicalTrials.gov
CT-322	DRUG	Phase PHASE2	Colorectal Cancer (CRC)	ClinicalTrials.gov
Leucovorin calcium	DRUG	Phase PHASE2	Colorectal Cancer (CRC)	ClinicalTrials.gov
5-Fluorouracil (infusional)	DRUG	Phase PHASE2	Colorectal Cancer (CRC)	ClinicalTrials.gov
5-Fluorouracil (bolus)	DRUG	Phase PHASE2	Colorectal Cancer (CRC)	ClinicalTrials.gov
Methotrexate, Leucovorin and BMS-986142	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-817378	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Ipilimumab+ Budesonide	DRUG	Phase PHASE2	Malignant Melanoma	ClinicalTrials.gov
Ipilimumab+ Placebo	DRUG	Phase PHASE2	Malignant Melanoma	ClinicalTrials.gov
Apixaban + Placebo	DRUG	Phase PHASE3	Deep Vein Thrombosis	ClinicalTrials.gov
Enoxaparin + Placebo	DRUG	Phase PHASE3	Deep Vein Thrombosis	ClinicalTrials.gov
BMS-791325	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
FDC of Norethindrone and Ethinyl Estradiol	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
FDC of Daclatasvir, Asunaprevir and BMS-791325	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Brivanib Placebo	DRUG	Phase PHASE1	Metastatic Colorectal Cancer (MCRC)	ClinicalTrials.gov
KOS-1584	DRUG	Phase PHASE2	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Kcentra	DRUG	Phase PHASE1	Thrombosis	ClinicalTrials.gov
Placebo matching BMS-986147	DRUG	Phase PHASE1	Healthy	ClinicalTrials.gov
BMS-986147	DRUG	Phase PHASE1	Healthy	ClinicalTrials.gov
Apixaban-matching placebo	DRUG	Phase PHASE3	Deep Vein Thrombosis	ClinicalTrials.gov
Enoxaparin-matching placebo	DRUG	Phase PHASE3	Deep Vein Thrombosis	ClinicalTrials.gov
Tenofovir	DRUG	Phase PHASE2	HIV-1 Infection	ClinicalTrials.gov
Efavirenz	DRUG	Phase PHASE2	HIV-1 Infection	ClinicalTrials.gov
Placebo matching with BMS-986001	DRUG	Phase PHASE2	HIV-1 Infection	ClinicalTrials.gov
BMS-986001	DRUG	Phase PHASE2	HIV-1 Infection	ClinicalTrials.gov
Abatacept (BMS-188667)	BIOLOGICAL	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Belatacept MI (more intensive)	DRUG	Phase PHASE3	Kidney Transplantation	ClinicalTrials.gov
Belatacept LI (less intensive)	DRUG	Phase PHASE3	Kidney Transplantation	ClinicalTrials.gov
Cyclosporine (CsA)	DRUG	Phase PHASE3	Kidney Transplantation	ClinicalTrials.gov
BMS-790052	DRUG	Phase PHASE2	Hepatitis C Virus	ClinicalTrials.gov
metreleptin	DRUG	Approved	Lipodystrophy	ClinicalTrials.gov
Placebo matching Daclatasvir	DRUG	Phase PHASE3	Hepatitis C Virus (HCV)	ClinicalTrials.gov
Pegylated interferon alfa-2a (pegIFNα-2a)	BIOLOGICAL	Phase PHASE3	Hepatitis C Virus (HCV)	ClinicalTrials.gov
Pegylated interferon lambda (pegIFNλ)	BIOLOGICAL	Phase PHASE3	Hepatitis C Virus (HCV)	ClinicalTrials.gov
Comprehensive non invasive cardiovascular examination	OTHER	Preclinical	Coronary Heart Disease	ClinicalTrials.gov
BMS-982470 (recombinant interleukin-21)	BIOLOGICAL	Phase PHASE1	Melanoma	ClinicalTrials.gov
Peg-interferon alfa-2a	DRUG	Phase PHASE2	Hepatitis C Virus	ClinicalTrials.gov
Antacid Buffer Predose Solution	DRUG	Phase PHASE1	Healthy Adult Normals	ClinicalTrials.gov
Placebo matching with BMS-933043	DRUG	Phase PHASE1	Healthy Adult Normals	ClinicalTrials.gov
BMS-933043	DRUG	Phase PHASE1	Healthy Adult Normals	ClinicalTrials.gov
Anti-CD137 (4-1BB) (BMS-663513)	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Alvespimycin	DRUG	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Epofolate	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Nilutamide	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Placebo matching BMS-986094/INX-08189	DRUG	Preclinical	Healthy	ClinicalTrials.gov
BMS-986094/INX-08189	DRUG	Preclinical	Healthy	ClinicalTrials.gov
vinflunine + ixabepilone	DRUG	Phase PHASE1	Cancer	ClinicalTrials.gov
Subcutaneous (SC) abatacept	DRUG	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Intravenous (IV) abatacept	DRUG	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
ABA, open-label (OL)	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
PLA + MTX switched to ABA+ MTX, DB	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Placebo (PLA) + MTX, DB	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Infliximab (INF) + MTX, DB	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Placebo for BMS-986094	DRUG	Phase PHASE2	Hepatitis C Virus	ClinicalTrials.gov
BMS-986094	DRUG	Phase PHASE2	Hepatitis C Virus	ClinicalTrials.gov
ixabepilone	DRUG	Phase PHASE2	Non-squamous Non-small Cell Lung Cancer	ClinicalTrials.gov
Aspirin	DRUG	Phase PHASE4	Coronary Graft Patency	ClinicalTrials.gov
sugar pill	DRUG	Phase PHASE4	Coronary Graft Patency	ClinicalTrials.gov
clopidogrel	DRUG	Phase PHASE4	Coronary Graft Patency	ClinicalTrials.gov
nilotinib	DRUG	Preclinical	Chronic Myeloid Leukemia (CML)	ClinicalTrials.gov
diabetes self management support	OTHER	Approved	Diabetes Mellitus Type 2	ClinicalTrials.gov
Midazolam	DRUG	Phase PHASE1	Healthy Adult Volunteers	ClinicalTrials.gov
BMS-986120	DRUG	Phase PHASE1	Healthy Adult Volunteers	ClinicalTrials.gov
Atazanavir	DRUG	Phase PHASE4	HIV Infections	ClinicalTrials.gov
vinflunine + ketaconazole	DRUG	Phase PHASE1	Cancer	ClinicalTrials.gov
BMS-690514	DRUG	Phase PHASE2	Non-Small-Cell Lung Carcinoma	ClinicalTrials.gov
Anti-CXCR4 (BMS-936564)	BIOLOGICAL	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Conformal Thoracic Radiotherapy (CTRT)	RADIATION	Phase PHASE2	Lung Cancer	ClinicalTrials.gov
Ipilimumab, 10 mg	DRUG	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Ipilimumab, 3 mg	DRUG	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Group B (Baraclude, Viread)	DRUG	Phase PHASE4	Chronic Hepatitis B	ClinicalTrials.gov
Group A (Zeffix, Sebivo, Hepsera)	DRUG	Phase PHASE4	Chronic Hepatitis B	ClinicalTrials.gov
peripheral blood stem cell transplantation	PROCEDURE	Phase PHASE2	Lymphoma	ClinicalTrials.gov
vincristine sulfate	DRUG	Phase PHASE2	Lymphoma	ClinicalTrials.gov
ifosfamide	DRUG	Phase PHASE2	Lymphoma	ClinicalTrials.gov
doxorubicin hydrochloride	DRUG	Phase PHASE2	Lymphoma	ClinicalTrials.gov
filgrastim	BIOLOGICAL	Phase PHASE2	Lymphoma	ClinicalTrials.gov
Entecavir Placebo	DRUG	Phase PHASE4	Chronic Hepatitis B	ClinicalTrials.gov
Lamivudine Placebo	DRUG	Phase PHASE4	Chronic Hepatitis B	ClinicalTrials.gov
Clarithromycin	DRUG	Phase PHASE1	Venous Thromboembolism	ClinicalTrials.gov
Brivanib alaninate	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Mycophenolate mofetil (MMF)	DRUG	Phase PHASE2	Systemic Lupus Erythematosus	ClinicalTrials.gov
Corticosteroids (prednisone or prednisolone)	DRUG	Phase PHASE2	Systemic Lupus Erythematosus	ClinicalTrials.gov
BMS-820836 Placebo	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
Escitalopram	DRUG	Phase PHASE2	Depression	ClinicalTrials.gov
Group 2 (DMARDS treated group)	OTHER	Phase PHASE4	Apoptotic DNA Damage	ClinicalTrials.gov
Group 1 or Orencia treated group	DRUG	Phase PHASE4	Apoptotic DNA Damage	ClinicalTrials.gov
DCV 3DAA FDC	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
BMS-823778	DRUG	Phase PHASE2	Dyslipidemia	ClinicalTrials.gov
Nulojix	DRUG	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
PEG-Interferon alfa 2a	DRUG	Phase PHASE3	Hepatitis C, Genotype 1	ClinicalTrials.gov
Dabrafenib	DRUG	Phase PHASE1	Metastatic Melanoma	ClinicalTrials.gov
Tanespimycin	DRUG	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
Placebo matching BMS-791325	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Atorvastatin	DRUG	Phase PHASE1	Acute Coronary Syndromes	ClinicalTrials.gov
BMS-919373	DRUG	Phase PHASE1	Acute Coronary Syndromes	ClinicalTrials.gov
BMS-830216	DRUG	Phase PHASE1	Obesity	ClinicalTrials.gov
Asunaprevir	DRUG	Phase PHASE1	Hepatitis C Infection	ClinicalTrials.gov
Magnetic Resonance Imaging without Contrast	PROCEDURE	Approved	Thrombosis	ClinicalTrials.gov
Magnetic Resonance Imaging with Contrast	DRUG	Approved	Thrombosis	ClinicalTrials.gov
Ultrasound	PROCEDURE	Approved	Thrombosis	ClinicalTrials.gov
Adefovir	DRUG	Phase PHASE4	Hepatitis B, Chronic	ClinicalTrials.gov
Anti-PDL-1 antibody	BIOLOGICAL	Phase PHASE1	Cancer, Multiple Indications	ClinicalTrials.gov
DCV/ASV/BMS-791325 + RBV	DRUG	Approved	Hepatitis C	ClinicalTrials.gov
DCV/ASV/BMS-791325	DRUG	Approved	Hepatitis C	ClinicalTrials.gov
BMS-936564 (Anti-CXCR4)	DRUG	Phase PHASE1	Acute Myelogenous Leukemia	ClinicalTrials.gov
Ortho Tri-Cyclen®	DRUG	Phase PHASE1	Chronic Hepatitis C	ClinicalTrials.gov
Pegylated-interferon alfa-2a	DRUG	Phase PHASE2	Chronic Hepatitis C	ClinicalTrials.gov
BMS-650032	DRUG	Phase PHASE2	Chronic Hepatitis C	ClinicalTrials.gov
Placebo for Ribavirin (RBV)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Placebo (PBO) for BMS-790052 (Placebo for NS5A Inhibitor)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Placebo (PBO) for BMS-650032 (Placebo for NS3 Protease Inhibitor)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
BMS-650032 (NS3 Protease Inhibitor)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
BMS-790052 (NS5A Inhibitor)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Ribavirin (RBV)	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
abatacept (Orencia ®)	DRUG	Phase PHASE1	Urticaria	ClinicalTrials.gov
Ritonavir boosted Atazanavir + 2 NRTIs	DRUG	Phase PHASE4	HIV Infection	ClinicalTrials.gov
Ritonavir boosted Atazanavir + Lamivudine	DRUG	Phase PHASE4	HIV Infection	ClinicalTrials.gov
Extension of Care	OTHER	Approved	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Cetuximab (Erbitux, C225)	DRUG	Phase PHASE1	Malignant Solid Tumour	ClinicalTrials.gov
erlotinib with cetuximab	DRUG	Phase PHASE1	Lung Adenocarcinoma	ClinicalTrials.gov
BMS-833923	DRUG	Phase PHASE1	Leukemia	ClinicalTrials.gov
MDX-1100	BIOLOGICAL	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
sterile saline for injection	BIOLOGICAL	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
BMS-963272	DRUG	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo for warfarin	DRUG	Phase PHASE3	Venous Thrombosis	ClinicalTrials.gov
Placebo for enoxaparin	DRUG	Phase PHASE3	Venous Thrombosis	ClinicalTrials.gov
Placebo for apixaban	DRUG	Phase PHASE3	Venous Thrombosis	ClinicalTrials.gov
6 Minute Walk Test	PROCEDURE	Approved	Acute Heart Failure	ClinicalTrials.gov
Rifampin	DRUG	Phase PHASE1	Cancer	ClinicalTrials.gov
Vinflunine	DRUG	Phase PHASE1	Cancer	ClinicalTrials.gov
Surgical Resection	PROCEDURE	Phase PHASE2	Melanoma	ClinicalTrials.gov
Bevacizumab placebo (ie saline solution)	DRUG	Phase PHASE2	Non-small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Methotrexate placebo	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Abatacept placebo	DRUG	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-650032 (Asunaprevir)	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
BMS-790052 (Daclatasvir)	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Risperidone/Quetiapine	DRUG	Preclinical	Psychotic Disorders	ClinicalTrials.gov
FV-100 placebo	DRUG	Phase PHASE2	Herpes Zoster	ClinicalTrials.gov
Valacyclovir placebo	DRUG	Phase PHASE2	Herpes Zoster	ClinicalTrials.gov
FV-100	DRUG	Phase PHASE2	Herpes Zoster	ClinicalTrials.gov
valacyclovir	DRUG	Phase PHASE2	Herpes Zoster	ClinicalTrials.gov
Guidelines	BEHAVIORAL	Phase PHASE4	Coronary Heart Disease	ClinicalTrials.gov
Updated CHD risk profiles	BEHAVIORAL	Phase PHASE4	Coronary Heart Disease	ClinicalTrials.gov
Placebo BID Fasted	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
100 mg INX-08189 BID Fasted	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Placebo with low-fat meal	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
100 mg INX-08189 with low-fat meal	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Placebo QD	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
100 mg INX-08189 QD	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Placebo QD Fasted	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
200 mg INX-08189 Fasted	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
BMS-986142	DRUG	Phase PHASE1	Healthy Adult	ClinicalTrials.gov
Subcutaneous(SC) Abatacept	DRUG	Phase PHASE3	Rheumatoid Arthritis (RA)	ClinicalTrials.gov
Haloperidol	DRUG	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
Olanzapine	DRUG	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
Asunaprevir, Daclatasvir, Ribavirin and Peginterferon alfa-2a	DRUG	Phase PHASE2	HCV-HIV Co-Infection	ClinicalTrials.gov
Montelukast	DRUG	Phase PHASE1	Drug-drug Interaction Study	ClinicalTrials.gov
Atazanavir/Cobicistat FDC	DRUG	Phase PHASE1	Human Immunodeficiency Virus Type 1 (HIV-1)	ClinicalTrials.gov
Cobicistat	DRUG	Phase PHASE1	Human Immunodeficiency Virus Type 1 (HIV-1)	ClinicalTrials.gov
BMS-741672	DRUG	Phase PHASE2	Neuropathic Pain	ClinicalTrials.gov
ipilimumab (MDX-010, BMS-734016)	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Best Supportive care (BSC)	OTHER	Phase PHASE2	Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction	ClinicalTrials.gov
PegIFN lambda	DRUG	Phase PHASE2	Hepatitis B Virus	ClinicalTrials.gov
pegIFNα-2a	DRUG	Phase PHASE2	Hepatitis B Virus	ClinicalTrials.gov
pegIFN	DRUG	Phase PHASE2	Hepatitis B Virus	ClinicalTrials.gov
Radical Cystectomy	PROCEDURE	Approved	Transitional Cell Carcinoma of the Bladder	ClinicalTrials.gov
RQ-PCR RNA Analysis	OTHER	Preclinical	Chronic Myelocytic Leukemia	ClinicalTrials.gov
BMS-936557 (Anti-IP-10 Antibody)	DRUG	Phase PHASE2	Crohn's Disease	ClinicalTrials.gov
Healthy volunteers	OTHER	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
Risperidone	DRUG	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
mood stabilizer	DRUG	Approved	Bipolar Disorder	ClinicalTrials.gov
Enhanced Clinical Intervention	BEHAVIORAL	Approved	Bipolar Disorder	ClinicalTrials.gov
BMS-582949	DRUG	Phase PHASE2	Psoriasis	ClinicalTrials.gov
pexacerfont	DRUG	Phase PHASE2	Generalized Anxiety Disorder	ClinicalTrials.gov
Placebo matching BMS-241027	DRUG	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
BMS-241027	DRUG	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
BMS-708163	DRUG	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Atenolol	DRUG	Phase PHASE1	N/A - Healthy Subjects	ClinicalTrials.gov
BMS-908662	DRUG	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
MDX-010	DRUG	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
BMS-986104	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Denenicokin	BIOLOGICAL	Phase PHASE1	Neoplasms by Site	ClinicalTrials.gov
Ex-vivo analysis	OTHER	Preclinical	HIV	ClinicalTrials.gov
Tenofovir/Emtricitabine	DRUG	Phase PHASE4	HIV, Combination Therapy	ClinicalTrials.gov
Raltegravir	DRUG	Phase PHASE4	HIV, Combination Therapy	ClinicalTrials.gov
Ritonavir (heat-stable)	DRUG	Phase PHASE4	HIV, Combination Therapy	ClinicalTrials.gov
Trastuzumab	DRUG	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Keyhole limpet hemocyanin	DRUG	Phase PHASE1	Healthy Adult Volunteers	ClinicalTrials.gov
Placebo matching with BMS-986090	DRUG	Phase PHASE1	Healthy Adult Volunteers	ClinicalTrials.gov
BMS-986090	DRUG	Phase PHASE1	Healthy Adult Volunteers	ClinicalTrials.gov
Strata 3 CXL-1020	DRUG	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Strata 2 CXL-1020	DRUG	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Strata 1 CXL-1020	DRUG	Phase PHASE2	Heart Failure	ClinicalTrials.gov
DCV/ASV/BCV	DRUG	Phase PHASE4	Hepatitis C, Chronic	ClinicalTrials.gov
Pelvic irradiation	RADIATION	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
5-fluorouracil	DRUG	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
Placebo matching with BMS-981164	BIOLOGICAL	Phase PHASE1	Healthy Subjects and Atopic Dermatitis Subjects	ClinicalTrials.gov
BMS-981164	BIOLOGICAL	Phase PHASE1	Healthy Subjects and Atopic Dermatitis Subjects	ClinicalTrials.gov
Pegylated-interferon alfa 2a (PegIFN)	DRUG	Phase PHASE3	Hepatitis C Virus	ClinicalTrials.gov
Daclatasvir (DCV)	DRUG	Phase PHASE3	Hepatitis C Virus	ClinicalTrials.gov
Asunaprevir (ASV)	DRUG	Phase PHASE3	Hepatitis C Virus	ClinicalTrials.gov
Statin	DRUG	Phase PHASE2	Vascular Diseases	ClinicalTrials.gov
CCR2 Antagonist	DRUG	Phase PHASE2	Type 2 Diabetes	ClinicalTrials.gov
Peginterferon Lambda-1a (BMS-914143)	DRUG	Preclinical	Hepatitis C	ClinicalTrials.gov
Ipilimumab and nivolumab	DRUG	Phase PHASE3	Brain Metastases	ClinicalTrials.gov
Fotemustine and Ipilimumab	DRUG	Phase PHASE3	Brain Metastases	ClinicalTrials.gov
Fotemustine	DRUG	Phase PHASE3	Brain Metastases	ClinicalTrials.gov
Avagacestat	DRUG	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Thymoglobulin	DRUG	Phase PHASE2	Disorder Related to Renal Transplantation	ClinicalTrials.gov
Cyclosporine	DRUG	Phase PHASE2	Graft Rejection	ClinicalTrials.gov
BMS-954561	DRUG	Phase PHASE2	Post-Herpetic Neuralgia (PHN)	ClinicalTrials.gov
Daily dosing with Zileuton/Dasatinib for CML	DRUG	Phase PHASE1	Chronic Myelogenous Leukemia	ClinicalTrials.gov
Daily dosing of Zileuton/Dasatinib	DRUG	Phase PHASE1	Chronic Myelogenous Leukemia	ClinicalTrials.gov
Dosing with Zileuton/Dasatinib in CML	DRUG	Phase PHASE1	Chronic Myelogenous Leukemia	ClinicalTrials.gov
Zileuton (Zyflo®) Dasatinib (Sprycel®)	DRUG	Phase PHASE1	Chronic Myelogenous Leukemia	ClinicalTrials.gov
BMS-914392	DRUG	Phase PHASE2	Atrial Fibrillation	ClinicalTrials.gov
Standard treatment regimen	OTHER	Approved	Acquired Immune Deficiency Syndrome	ClinicalTrials.gov
BMS-986115	DRUG	Phase PHASE1	Various Advanced Cancer	ClinicalTrials.gov
BMS-663513	DRUG	Phase PHASE1	Tumors	ClinicalTrials.gov
.Asunaprevir, Daclatasvir and BMS - 791325	DRUG	Phase PHASE2	Hepatitis C Virus Genotype 4 Infection	ClinicalTrials.gov
Paclitaxel and carboplatin	DRUG	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Letrozole	DRUG	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Lapatinib	DRUG	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Dasatinib, 140 mg + Lenalidomide, 25 mg + Dexamethasone, 40 mg	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Dasatinib, 100 mg + Lenalidomide, 25 mg + Dexamethasone, 40 mg	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Dasatinib, 100 mg + Lenalidomide, 20 mg + Dexamethasone, 40 mg	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Dasatinib, 70 mg + Lenalidomide, 20 mg + Dexamethasone, 40 mg	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Dasatinib, 70 mg + Lenalidomide, 15 mg + Dexamethasone, 40 mg	DRUG	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Imatinib	DRUG	Phase PHASE2	Leukemia	ClinicalTrials.gov
Dasatinib, Mitoxantrone, Cytarabine	DRUG	Phase PHASE1	Leukemia	ClinicalTrials.gov
pegIFNα-2b	BIOLOGICAL	Phase PHASE3	Hepatitis C Virus Infection	ClinicalTrials.gov
atazanavir 300mg boosted with ritonavir 50 mg	DRUG	Phase PHASE1	HIV Infection	ClinicalTrials.gov
Lopinavir/Ritonavir	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Ritonavir	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Darunavir	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
GM-CSF	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Daclatasvir, Asunaprevir and BMS-791325 FDC	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Vemurafenib	DRUG	Phase PHASE1	Melanoma	ClinicalTrials.gov
Ipilimumab (BMS-734016)	DRUG	Phase PHASE1	Melanoma	ClinicalTrials.gov
Dasatinib in combination with imatinib	DRUG	Phase PHASE1	Myeloid Leukemia, Chronic, Chronic-Phase	ClinicalTrials.gov
BMS-986142 350mg	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-986142 200mg	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Pegylated interferon alfa-2a	DRUG	Phase PHASE2	Hepatitis C Virus	ClinicalTrials.gov
Paclitaxel, vinorelbine, cisplatin	DRUG	Phase PHASE2	NSCLC Stage IIIB	ClinicalTrials.gov
PSI-7977	DRUG	Phase PHASE2	Chronic Hepatitis C	ClinicalTrials.gov
No Intervention	DRUG	Preclinical	HIV-1	ClinicalTrials.gov
BMS-817399	DRUG	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Comparator: placebo	DRUG	Phase PHASE3	Type 2 Diabetes Mellitus	ClinicalTrials.gov
MK0478 (muraglitazar)	DRUG	Phase PHASE3	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Cdc7-inhibitor (BMS-863233)	DRUG	Phase PHASE1	Refractory Hematologic Cancer	ClinicalTrials.gov
Dextromethorphan	DRUG	Phase PHASE4	Transplant Rejection	ClinicalTrials.gov
Caffeine	DRUG	Phase PHASE4	Transplant Rejection	ClinicalTrials.gov
MK-0646	DRUG	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
[13C]-BMS-791325	DRUG	Phase PHASE1	Hepatitis C Virus Infection	ClinicalTrials.gov
INX-08189	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Placebo matching with INX-08189	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
BMS-833923 (XL139)	DRUG	Phase PHASE1	Hedgehog Pathway	ClinicalTrials.gov
Abatacept or Placebo (both as IV & SC solution)	DRUG	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Salsalate	DRUG	Phase PHASE2	HIV	ClinicalTrials.gov
Entecavir + Tenofovir (MDR group)	DRUG	Phase PHASE4	Chronic Hepatitis B	ClinicalTrials.gov
Tissue Sample	PROCEDURE	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
Anti-IP-10 Antibody	DRUG	Phase PHASE2	Colitis, Ulcerative	ClinicalTrials.gov
Naloxone	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Buprenorphine	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Methadone	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Pegylated-interferon alfa 2a	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Placebo matching BMS-790052	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
BMS-790052 (NS5A Replication Complex Inhibitor)	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
Corticosteroid: Triamcinolone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Prednisone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Prednisolone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Methylprednisolone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Meprednisone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Hydrocortisone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Fludrocortisone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Dexamethasone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
Corticosteroid: Betamethasone	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
MDX-1106	BIOLOGICAL	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Erlotinib and Dasatinib	DRUG	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Gemcitabine,	DRUG	Phase PHASE2	Bladder Cancer	ClinicalTrials.gov
Placebo (Saline solution)	DRUG	Phase PHASE1	Anticoagulation	ClinicalTrials.gov
Beriplex P/N (4-Factor PCC)	DRUG	Phase PHASE1	Anticoagulation	ClinicalTrials.gov
Cofact (4-Factor PCC)	DRUG	Phase PHASE1	Anticoagulation	ClinicalTrials.gov
Cocktail	DRUG	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
Emtricitabine/tenofovir disoproxil fumarate	DRUG	Phase PHASE3	HIV Infection	ClinicalTrials.gov
Sertraline	DRUG	Phase PHASE1	Hepatitis C Infection	ClinicalTrials.gov
Ribasphere	DRUG	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Pegylated Interferon Lambda	BIOLOGICAL	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Rezolsta	DRUG	Phase PHASE1	HIV	ClinicalTrials.gov
Evotaz	DRUG	Phase PHASE1	HIV	ClinicalTrials.gov
No Intervention (subjects were previously treated with Orencia®)	DRUG	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Abatacept (Orencia)	DRUG	Phase PHASE2	ANCA-associated Vasculitis	ClinicalTrials.gov
Clinical-guided dosing algorithm for warfarin	BEHAVIORAL	Phase PHASE3	Stroke	ClinicalTrials.gov
Genotype-guided dosing algorithm for warfarin	BEHAVIORAL	Phase PHASE3	Stroke	ClinicalTrials.gov
[14C] BMS-986020	DRUG	Phase PHASE1	Immunosuppression For Disease	ClinicalTrials.gov
Methotrexate (MTX)	DRUG	Phase PHASE3	Rheumatoid Arthritis (RA)	ClinicalTrials.gov
MDX-060	DRUG	Phase PHASE2	Hodgkin's Disease	ClinicalTrials.gov
Paracetamol	DRUG	Phase PHASE4	Pain	ClinicalTrials.gov
Placebo for Asunaprevir	OTHER	Phase PHASE3	Hepatitis C Virus Infection	ClinicalTrials.gov
Placebo for Daclatasvir	OTHER	Phase PHASE3	Hepatitis C Virus Infection	ClinicalTrials.gov
Placebo for DCV 3DAA	OTHER	Phase PHASE3	Hepatitis C Virus Infection	ClinicalTrials.gov
DCV 3DAA	DRUG	Phase PHASE3	Hepatitis C Virus Infection	ClinicalTrials.gov
cetuximab with irinotecan	DRUG	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
Radiation	RADIATION	Phase PHASE2	Gastric Cancer	ClinicalTrials.gov
abatacept (ABA)	DRUG	Phase PHASE3	Ulcerative Colitis	ClinicalTrials.gov
Peginterferon alfa-2b	DRUG	Phase PHASE2	Hepatitis C Infection	ClinicalTrials.gov
follow-up	OTHER	Preclinical	Hepatitis B, Chronic	ClinicalTrials.gov
Placebo matching Ribavirin	DRUG	Phase PHASE3	Hepatitis C	ClinicalTrials.gov
CXL-1020 Doses for Echo Cohort B	DRUG	Phase PHASE1	Heart Failure	ClinicalTrials.gov
CXL-1020 Dose for Echo Cohort A	DRUG	Phase PHASE1	Heart Failure	ClinicalTrials.gov
Placebo for CXL-1020 Cohort 2	DRUG	Phase PHASE1	Heart Failure	ClinicalTrials.gov
Placebo for CXL-1020 Cohort 1	DRUG	Phase PHASE1	Heart Failure	ClinicalTrials.gov
CXL-1020	DRUG	Phase PHASE1	Heart Failure	ClinicalTrials.gov
BMS-770767	DRUG	Phase PHASE2	Diabetes Type 2	ClinicalTrials.gov
Diltiazem ER	DRUG	Phase PHASE1	Thrombosis	ClinicalTrials.gov
Itraconazole	DRUG	Phase PHASE1	Thrombosis	ClinicalTrials.gov
BMS-986177	DRUG	Phase PHASE1	Thrombosis	ClinicalTrials.gov
Placebo matching Pregabalin	DRUG	Phase PHASE2	Diabetic Peripheral Neuropathic Pain	ClinicalTrials.gov
Placebo matching BMS-954561	DRUG	Phase PHASE2	Diabetic Peripheral Neuropathic Pain	ClinicalTrials.gov
Pregabalin	DRUG	Phase PHASE2	Diabetic Peripheral Neuropathic Pain	ClinicalTrials.gov
Placebo matching with BMS-823778	DRUG	Phase PHASE2	Hypertension	ClinicalTrials.gov
Ustekinumab Placebo	OTHER	Phase PHASE2	Active Psoriatic Arthritis	ClinicalTrials.gov
BMS-986165 Dose B	DRUG	Phase PHASE2	Active Psoriatic Arthritis	ClinicalTrials.gov
BMS-986165 Dose A	DRUG	Phase PHASE2	Active Psoriatic Arthritis	ClinicalTrials.gov
BMS-986165 Placebo	OTHER	Phase PHASE2	Active Psoriatic Arthritis	ClinicalTrials.gov
Anti-IL8	BIOLOGICAL	Preclinical	None	ClinicalTrials.gov
BMS-986158	DRUG	Phase PHASE1	Advanced Tumors	ClinicalTrials.gov
BMS-986036	DRUG	Phase PHASE1	Moderate Liver Impairment	ClinicalTrials.gov
Low dose doxorubicin	DRUG	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
BMS-986165 Tablet formulation 2	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986165 Tablet formulation 1	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Pazopanib	BIOLOGICAL	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
no intervention is given	OTHER	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-986172	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986235	DRUG	Phase PHASE1	Mediators of Inflammation	ClinicalTrials.gov
Non-Interventional	OTHER	Preclinical	Non-Small Cell Lung Cancer	ClinicalTrials.gov
VKA	DRUG	Preclinical	Anticoagulation	ClinicalTrials.gov
HF10	DRUG	Phase PHASE2	Melanoma	ClinicalTrials.gov
BMS-986310	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Nivolumab plus Relatlimab FDC	BIOLOGICAL	Preclinical	None	ClinicalTrials.gov
Leukapheresis for research	PROCEDURE	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Research blood draw	PROCEDURE	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
NeoVax	BIOLOGICAL	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
BMS-986299	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Active Pharmaceutical Ingredient	DRUG	Phase PHASE1	HIV in Adults	ClinicalTrials.gov
BMS-986166	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
ImmunOncoTool Condition	BEHAVIORAL	Approved	Cancer	ClinicalTrials.gov
Nivolumab/Ipilimumab	BIOLOGICAL	Phase PHASE2	Transitional Cell Carcinoma	ClinicalTrials.gov
BMS-936558 (Anti-PD-1)	DRUG	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Placebo matching Dacarbazine	DRUG	Phase PHASE3	Melanoma	ClinicalTrials.gov
Placebo matching BMS-936558 (Nivolumab)	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
BMS-936558 (Nivolumab)	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
No systemic anticoagulant prophylaxis	OTHER	Phase PHASE3	Lymphoma	ClinicalTrials.gov
Kinevac®	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
[14C] BMS-986278	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Isatuximab	DRUG	Phase PHASE3	Newly Diagnosed Multiple Myeloma	ClinicalTrials.gov
Nevirapine	DRUG	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Placebos	DRUG	Phase PHASE3	Polymyalgia Rheumatica	ClinicalTrials.gov
Fluconazole	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Rifampin (Treatment B)	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986235 (Treatment A)	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Zalcitabine	DRUG	Approved	HIV Infections	ClinicalTrials.gov
DPV-001 vaccine	BIOLOGICAL	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Tetanus vaccine	BIOLOGICAL	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
BMS-986178	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Gemfibrozil	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Extended Phenytoin Sodium	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Alcohol	OTHER	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Prototype BMS-986165	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Reference Treatment- BMS-986165-01	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986256	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Tyrosinase/gp100/MART-1 Peptides	BIOLOGICAL	Phase PHASE2	Intraocular Melanoma	ClinicalTrials.gov
BMS-936558 (MDX-1106)	BIOLOGICAL	Phase PHASE1	Metastatic Castration-resistant Prostrate Cancer	ClinicalTrials.gov
BMS-986278 suspension	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Esomeprazole	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986278 Tablet	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Zoledronic Acid	DRUG	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
pneumococcal conjugate vaccine	BIOLOGICAL	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
pneumococcal polysaccharide vaccine	BIOLOGICAL	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
BMS-936558	DRUG	Phase PHASE2	Cholangiocarcinoma	ClinicalTrials.gov
gp160 Vaccine (Immuno-AG)	BIOLOGICAL	Phase PHASE1	HIV Infections	ClinicalTrials.gov
Diltiazem	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Danicamtiv	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Motolimod	DRUG	Phase EARLY_PHASE1	HNSCC	ClinicalTrials.gov
BMS-986259	DRUG	Phase PHASE2	Acute Decompensated Heart Failure	ClinicalTrials.gov
TIL + IL-2 + Nivolumab	DRUG	Phase PHASE1	Melanoma	ClinicalTrials.gov
Cytarabine	DRUG	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Eliquis	DRUG	Preclinical	NonValvular Atrial Fibrillation	ClinicalTrials.gov
Nivolumab Combined with Anlotinib	DRUG	Phase PHASE1	NSCLC Stage IV	ClinicalTrials.gov
IC	DRUG	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
ECF	DRUG	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
Interferon alfa-2b	DRUG	Phase PHASE2	Sarcoma, Kaposi	ClinicalTrials.gov
Branebrutinib	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Elotuzumab (BMS-901608; HuLuc63)	BIOLOGICAL	Phase PHASE3	Lymphoma	ClinicalTrials.gov
Dexamethasone (IV)	DRUG	Phase PHASE3	Lymphoma	ClinicalTrials.gov
Dexamethasone (Oral)	DRUG	Phase PHASE3	Lymphoma	ClinicalTrials.gov
Oregovomab	DRUG	Phase PHASE1	Epithelial Ovarian Cancer	ClinicalTrials.gov
Nivolumab 6 mg/kg IV	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
Ipilimumab 3 mg/kg IV	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
Nivolumab 1 mg/kg IV	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
Ipilimumab 1 mg/kg IV	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
Nivolumab 3 mg/kg IV	BIOLOGICAL	Phase PHASE3	Melanoma	ClinicalTrials.gov
BMS-986337 Placebo	OTHER	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986337	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Loestrin	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Calcineurin inhibitors (CNI)	DRUG	Preclinical	Kidney Transplantation	ClinicalTrials.gov
Infusion with nivolumab 1 mg/kg q3wks	DRUG	Phase PHASE1	Stage III Skin Melanoma	ClinicalTrials.gov
Infusion with ipilimumab 3 mg/kg q3wks	DRUG	Phase PHASE1	Stage III Skin Melanoma	ClinicalTrials.gov
Surgery of the tumor	PROCEDURE	Phase PHASE1	Stage III Skin Melanoma	ClinicalTrials.gov
Reyataz Atazanavir	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Atazanavir/Cobicistat	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Placebo matching BMS-963272	OTHER	Phase PHASE1	Nonalcoholic Fatty Liver Disease	ClinicalTrials.gov
BMS-986263	DRUG	Phase PHASE2	Hepatic Cirrhosis	ClinicalTrials.gov
Bleomycin sulfate	DRUG	Phase PHASE1	Sarcoma, Kaposi	ClinicalTrials.gov
Opdivo	BIOLOGICAL	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
BMS-986209 Placebo	OTHER	Phase PHASE1	Health Participants	ClinicalTrials.gov
BMS-986209	DRUG	Phase PHASE1	Health Participants	ClinicalTrials.gov
Nivolumab + Nab-paclitaxel	DRUG	Phase PHASE2	Muscle-Invasive Bladder Carcinoma	ClinicalTrials.gov
tadalafil	DRUG	Phase PHASE2	Non Small Cell Lung Cancer	ClinicalTrials.gov
MILs™ - NSCLC	BIOLOGICAL	Phase PHASE2	Non Small Cell Lung Cancer	ClinicalTrials.gov
Phenprocoumon	DRUG	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
Solu-medrol	DRUG	Phase PHASE1	Leukemia	ClinicalTrials.gov
Idarubicin	DRUG	Phase PHASE1	Leukemia	ClinicalTrials.gov
enadenotucirev	BIOLOGICAL	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
Yttrium Y 90 Glass Microspheres	RADIATION	Phase PHASE1	Stage IIIA Hepatocellular Carcinoma	ClinicalTrials.gov
Docetaxel/Paclitaxel	DRUG	Phase PHASE3	Esophageal Cancer	ClinicalTrials.gov
Everolimus	DRUG	Phase PHASE3	Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma	ClinicalTrials.gov
Milk of magnesia	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Fluvoxamine	DRUG	Phase PHASE1	Healthy	ClinicalTrials.gov
BMS-986205	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Furosemide	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Placebo (for BMS-986308)	OTHER	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986308	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Leukapheresis	PROCEDURE	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
Fecal samples	PROCEDURE	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
Peripheral blood	PROCEDURE	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
Tumor biopsy	PROCEDURE	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
TriGrid Delivery System	DEVICE	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
Neoantigen DNA vaccine	BIOLOGICAL	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
PROSTVAC-F	BIOLOGICAL	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
PROSTVAC-V	BIOLOGICAL	Phase PHASE1	Metastatic Hormone-Sensitive Prostate Cancer	ClinicalTrials.gov
Cabiralizumab	BIOLOGICAL	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Placebo (for BMS-986177)	OTHER	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Elotuzumab (BMS-901608)	BIOLOGICAL	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
NKTR-214	BIOLOGICAL	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Nivolumab & Ipilimumab	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Oral contraceptive	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
BMS-986148	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Esophagectomy (minimally invasive)	PROCEDURE	Phase PHASE2	Esophageal Squamous Cell Carcinoma	ClinicalTrials.gov
5Fluorouracil	DRUG	Phase PHASE2	Esophageal Squamous Cell Carcinoma	ClinicalTrials.gov
BMS-986322 Placebo	OTHER	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
IDO1 Inhibitor	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
DS-8273a	BIOLOGICAL	Phase PHASE1	Melanoma	ClinicalTrials.gov
Anastrozole	DRUG	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Carbamazepine	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Mogamulizumab + Nivolumab	BIOLOGICAL	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
Dasatinib Maximum Tolerated Dose	DRUG	Phase PHASE1	Non-Hodgkin's Lymphoma	ClinicalTrials.gov
branebrutinib placebo	DRUG	Phase PHASE2	Autoimmune Disorder	ClinicalTrials.gov
Ibrutinib	DRUG	Phase PHASE1	Waldenstrom's Macroglobulinemia	ClinicalTrials.gov
Ulocuplumab	DRUG	Phase PHASE1	Waldenstrom's Macroglobulinemia	ClinicalTrials.gov
APX005M	DRUG	Phase PHASE1	Advanced Melanoma	ClinicalTrials.gov
BMS-986012 (anti-fucosyl-GM1)	BIOLOGICAL	Phase PHASE1	Small Cell Lung Cancer	ClinicalTrials.gov
Apremilast	DRUG	Preclinical	Plaque Psoriasis	ClinicalTrials.gov
Lurbinectedin	DRUG	Phase PHASE1	Small-cell Lung Cancer	ClinicalTrials.gov
BMS-986207	DRUG	Phase PHASE2	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Gemcitabine-Releasing Intravesical System (GemRIS)/TAR-200	DRUG	Phase PHASE1	Bladder Cancer TNM Staging Primary Tumor (T) T2	ClinicalTrials.gov
Multiple Ascending Dose Placebo	OTHER	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Multiple Ascending Dose SC	BIOLOGICAL	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Placebo matching BMS-986326	OTHER	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
[14C]-BMS-986196	DRUG	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Custom study version of icompanion app	OTHER	Preclinical	Multiple Sclerosis	ClinicalTrials.gov
ONO-4538	DRUG	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Magnetic Resonance Imaging	PROCEDURE	Phase PHASE2	Recurrent Transformed Chronic Lymphocytic Leukemia	ClinicalTrials.gov
Bone Marrow Biopsy	PROCEDURE	Phase PHASE2	Recurrent Transformed Chronic Lymphocytic Leukemia	ClinicalTrials.gov
Methylprednisolone	DRUG	Phase PHASE2	Systemic Lupus Erythematosus Arthritis	ClinicalTrials.gov
Adjuvant nivolumab	DRUG	Phase PHASE3	Malignant Melanoma Stage III	ClinicalTrials.gov
Neoadjuvant ipilimumab + nivolumab	DRUG	Phase PHASE3	Malignant Melanoma Stage III	ClinicalTrials.gov
Cryoablation	PROCEDURE	Phase PHASE2	Soft Tissue Sarcoma	ClinicalTrials.gov
Nivolumab and Ipilimumab (5 mg/kg) Combination for Prostate Cancer	BIOLOGICAL	Phase PHASE2	Advanced Metastatic Cancer	ClinicalTrials.gov
Nivolumab and Ipilimumab (3 mg/kg) Combination for Prostate Cancer	BIOLOGICAL	Phase PHASE2	Advanced Metastatic Cancer	ClinicalTrials.gov
Nivolumab and Ipilimumab and Combination for Metastatic Cancer	BIOLOGICAL	Phase PHASE2	Advanced Metastatic Cancer	ClinicalTrials.gov
Nivolumab Monotherapy	BIOLOGICAL	Phase PHASE2	Advanced Metastatic Cancer	ClinicalTrials.gov
NT-I7	DRUG	Phase PHASE1	Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)	ClinicalTrials.gov
Marizomib	DRUG	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Neoadjuvant nivolumab in combination with platinum-based chemotherapy	DRUG	Preclinical	Resectable Non-small Cell Lung Cancer	ClinicalTrials.gov
Tegafur-gimeracil-oteracil potassium	DRUG	Phase PHASE3	Gastric Cancer	ClinicalTrials.gov
Degarelix	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Goserelin	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Leuprolide	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
ATG-017+Nivolumab	DRUG	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
ATG-017	DRUG	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
UV1 vaccine + leukine	BIOLOGICAL	Phase PHASE2	Cancer	ClinicalTrials.gov
Atazanavir/ritonavir monotherapy	DRUG	Phase PHASE3	HIV-1 Infection	ClinicalTrials.gov
Platinum	DRUG	Phase PHASE1	Small Cell Lung Cancer	ClinicalTrials.gov
BMS-986141	DRUG	Phase PHASE2	Coronary Artery Disease	ClinicalTrials.gov
Ticagrelor	DRUG	Phase PHASE2	Coronary Artery Disease	ClinicalTrials.gov
BMS-986325	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Celecoxib 200mg	DRUG	Phase PHASE2	Colon Carcinoma	ClinicalTrials.gov
Phenytoin	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Afimetoran	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Digital Health Coaching	BEHAVIORAL	Approved	Lymphoma	ClinicalTrials.gov
Bempegaldesleukin	BIOLOGICAL	Phase PHASE3	Bladder Cancer	ClinicalTrials.gov
Radical cystectomy (RC)	PROCEDURE	Phase PHASE3	Bladder Cancer	ClinicalTrials.gov
Radiotherapy	RADIATION	Phase PHASE2	Metastatic Pancreatic Cancer	ClinicalTrials.gov
Not treated	OTHER	Preclinical	Multiple Myeloma	ClinicalTrials.gov
Irinotecan Hydrochloride	DRUG	Phase PHASE2	Advanced Pancreatic Cancer	ClinicalTrials.gov
Onivyde	DRUG	Phase PHASE2	Advanced Pancreatic Cancer	ClinicalTrials.gov
Anti-CD137	BIOLOGICAL	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Pharmacological Study	OTHER	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Anti-PD-1	BIOLOGICAL	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Anti-LAG-3 Monoclonal Antibody BMS 986016	BIOLOGICAL	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
Systemic therapy	DRUG	Preclinical	Multiple Myeloma	ClinicalTrials.gov
No IMiD treatment	DRUG	Preclinical	Multiple Myeloma	ClinicalTrials.gov
IMiD treatment	DRUG	Preclinical	Multiple Myeloma	ClinicalTrials.gov
BMS-986446	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Low dose irradiation	RADIATION	Phase PHASE1	Stage IV Pancreatic Cancer	ClinicalTrials.gov
Stereotactic body radiation therapy	RADIATION	Phase PHASE1	Stage IV Pancreatic Cancer	ClinicalTrials.gov
Optimized NRTI backbone	DRUG	Phase PHASE3	HIV	ClinicalTrials.gov
Approved Hypertrophic Cardiomyopathy drug treatments	DRUG	Preclinical	Hypertrophic Cardiomyopathy (HCM)	ClinicalTrials.gov
Entinostat	DRUG	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Pelareorep	BIOLOGICAL	Phase PHASE1	Recurrent Plasma Cell Myeloma	ClinicalTrials.gov
No DMTs	DRUG	Preclinical	Multiple Sclerosis	ClinicalTrials.gov
Select DMTs other than ozanimod	DRUG	Preclinical	Multiple Sclerosis	ClinicalTrials.gov
BMS-986419 IR Tablet	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BMS-986419 DR Capsule	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Axitinib	DRUG	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
[177Lu]Lu-PSMA-617	RADIATION	Phase PHASE1	Very High Risk Prostate Carcinoma	ClinicalTrials.gov
Nivolumab, Ipilimumab	DRUG	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Mavacamten Capsule 3	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Mavacamten Capsule 2	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Mavacamten Capsule 1	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Vedolizumab	DRUG	Preclinical	Ulcerative Colitis	ClinicalTrials.gov
Steroids	DRUG	Preclinical	Ulcerative Colitis	ClinicalTrials.gov
TNF Inhibitor	DRUG	Preclinical	Ulcerative Colitis	ClinicalTrials.gov
Integrated Behavioral Care	BEHAVIORAL	Approved	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Veliparib	DRUG	Phase PHASE1	Advanced Solid Neoplasm	ClinicalTrials.gov
Fexofenadine	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
TLR9 Agonist SD-101	DRUG	Phase PHASE1	Advanced Malignant Solid Neoplasm	ClinicalTrials.gov
Anti-OX40 Antibody BMS 986178	BIOLOGICAL	Phase PHASE1	Advanced Malignant Solid Neoplasm	ClinicalTrials.gov
Radical Prostatectomy	PROCEDURE	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Leuprolide Acetate	DRUG	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Drospirenone/Ethinyl Estradiol	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Intensity-modulated radiotherapy	RADIATION	Phase PHASE2	Head and Neck Cancer	ClinicalTrials.gov
Fluorouracil/Adrucil	DRUG	Phase PHASE3	Head and Neck Cancer	ClinicalTrials.gov
Carboplatin/Paraplatin	DRUG	Phase PHASE3	Head and Neck Cancer	ClinicalTrials.gov
Cisplatin/Platinol	DRUG	Phase PHASE3	Head and Neck Cancer	ClinicalTrials.gov
Cetuximab/Erbitux	DRUG	Phase PHASE3	Head and Neck Cancer	ClinicalTrials.gov
autologous stem cell transplantation	PROCEDURE	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
CC-90010	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
[14C]CC-90010	DRUG	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Elotuzumab in combination with Lenalidomide and Dexamethasone	DRUG	Preclinical	Multiple Myeloma	ClinicalTrials.gov
Therapeutic Conventional Surgery	PROCEDURE	Phase EARLY_PHASE1	Borderline Resectable Pancreatic Adenocarcinoma	ClinicalTrials.gov
Rigosertib	DRUG	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
BMS-986196	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
oral azacitidine (CC-486)	DRUG	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
Placebo Comparator	OTHER	Phase PHASE2	Colitis, Ulcerative	ClinicalTrials.gov
BMS-986369	DRUG	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Baraclude	DRUG	Phase PHASE1	Hepatitis B Virus	ClinicalTrials.gov
brivanib (active)	DRUG	Phase PHASE2	Hepatocellular Carcinoma (HCC)	ClinicalTrials.gov
18F-PD-L1	OTHER	Approved	NSCLC Stage IV	ClinicalTrials.gov
Biopsies	PROCEDURE	Phase PHASE2	Malignant Melanoma Stage III	ClinicalTrials.gov
Blood for PBMCs	PROCEDURE	Phase PHASE2	Malignant Melanoma Stage III	ClinicalTrials.gov
Radiosurgery	RADIATION	Phase PHASE2	Clear-Cell Metastatic Renal Cell Carcinoma	ClinicalTrials.gov
Abatacept subcutaneous	DRUG	Phase PHASE3	Polymyositis	ClinicalTrials.gov
[14C]BMS-986419	DRUG	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
CC-486 300	DRUG	Phase PHASE2	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Bacillus Calmette-Guérin (BCG)	BIOLOGICAL	Phase PHASE3	Urinary Bladder Neoplasms	ClinicalTrials.gov
Chemoradiation	RADIATION	Phase PHASE2	Uterine Cervical Neoplasms	ClinicalTrials.gov
Ipilimumab 200 MG in 40 ML Injection	DRUG	Phase PHASE2	Uterine Cervical Neoplasms	ClinicalTrials.gov
Nivolumab 40 mg in 4 ml Injection	DRUG	Phase PHASE2	Uterine Cervical Neoplasms	ClinicalTrials.gov
Temozolomide 24month	DRUG	Phase PHASE2	Adenocarcinoma - GEJ	ClinicalTrials.gov
Temozolomide 3 month	DRUG	Phase PHASE2	Adenocarcinoma - GEJ	ClinicalTrials.gov
Temozolomide 50mg/m2/day	DRUG	Phase PHASE2	Adenocarcinoma - GEJ	ClinicalTrials.gov
Testosterone cypionate	DRUG	Phase PHASE2	Castration-resistant Prostate Cancer	ClinicalTrials.gov
Dobutamine: Perflutren Lipid Microsphere	OTHER	Preclinical	Evaluation of Troponin I Levels	ClinicalTrials.gov
Ipilimumab + nivolumab	DRUG	Phase PHASE2	Urothelial Carcinoma	ClinicalTrials.gov
DMARDs	DRUG	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha	DRUG	Phase PHASE1	Toxicity, Drug	ClinicalTrials.gov
177Lu-PSMA-617	DRUG	Phase PHASE2	Prostatic Neoplasms	ClinicalTrials.gov
CRS-207	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
GVAX Pancreas Vaccine	DRUG	Phase PHASE2	Pancreatic Cancer	ClinicalTrials.gov
Chemoradiotherapy	RADIATION	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
atazanavir 300 mg + ritonavir 100 mg + dolutegravir 50 mg	DRUG	Phase PHASE2	HIV-1 Infection	ClinicalTrials.gov
Activity monitor	OTHER	Approved	Leukemia, Acute	ClinicalTrials.gov
Education information system	BEHAVIORAL	Approved	Leukemia, Acute	ClinicalTrials.gov
Cellectra 2000	DEVICE	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
INO-5151 (Cohort C)	DRUG	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
Poly-ICLC (Cohort B)	DRUG	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
CDX-301 (Cohort B and C)	DRUG	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
Stereotactic body radiation therapy (SBRT) (Cohort B)	RADIATION	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
Nivolumab (Cohort A, B and C)	DRUG	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
NKTR-214 (Cohort A)	DRUG	Phase PHASE1	Metastatic Castration-resistant Prostate Cancer	ClinicalTrials.gov
Nivolumab Injection	DRUG	Phase PHASE1	Cervical Cancer	ClinicalTrials.gov
pilimumab	DRUG	Phase PHASE2	Advanced Stage Non-small Cell Lung Cancer	ClinicalTrials.gov
Brentuximab vedotin	BIOLOGICAL	Phase PHASE3	Hodgkin's Disease	ClinicalTrials.gov
Nivolumab plus Relatlimab	DRUG	Phase PHASE2	Squamous Cell Carcinoma of the Skin	ClinicalTrials.gov
binimetinib	DRUG	Phase PHASE1	Melanoma	ClinicalTrials.gov
encorafenib	DRUG	Phase PHASE1	Melanoma	ClinicalTrials.gov
Standard of care	OTHER	Phase PHASE2	COVID-19	ClinicalTrials.gov
Nivolumab +/- ipilimumab	DRUG	Preclinical	Melanoma	ClinicalTrials.gov
Fedratinib Oral Capsule 400 mg	DRUG	Phase PHASE1	Myeloproliferative Neoplasm	ClinicalTrials.gov
Decitabine 20 mg/m2	DRUG	Phase PHASE1	Myeloproliferative Neoplasm	ClinicalTrials.gov
Fedratinib Oral Capsule 300 mg	DRUG	Phase PHASE1	Myeloproliferative Neoplasm	ClinicalTrials.gov
XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)	DEVICE	Phase PHASE4	Chronic Total Occlusion of Coronary Artery	ClinicalTrials.gov
clopidogrel + aspirin OR prasugrel + aspirin	DRUG	Phase PHASE4	Chronic Total Occlusion of Coronary Artery	ClinicalTrials.gov
placebo + aspirin	DRUG	Phase PHASE4	Chronic Total Occlusion of Coronary Artery	ClinicalTrials.gov
Placebo for BMS-919373	DRUG	Phase PHASE1	Atrial Fibrillation	ClinicalTrials.gov
Sotalol	DRUG	Phase PHASE1	Atrial Fibrillation	ClinicalTrials.gov
a PD-1 inhibitor	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
AGEN1777	DRUG	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
lucitanib	DRUG	Phase PHASE1	Carcinoma, Non-small Cell Lung Cancer	ClinicalTrials.gov
ramucirumab	BIOLOGICAL	Phase PHASE1	Carcinoma, Non-small Cell Lung Cancer	ClinicalTrials.gov
BMS-986447	DRUG	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Iberdomide Hydrochloride	DRUG	Phase PHASE2	Smoldering Plasma Cell Myeloma	ClinicalTrials.gov
Cisplatin or Carboplatin	DRUG	Phase PHASE1	Malignant Pleural Mesothelioma	ClinicalTrials.gov
Cabazitaxel	DRUG	Phase PHASE2	Metastatic Prostate Neuroendocrine Carcinoma	ClinicalTrials.gov

💼 Business Developments:

Partnership
Acquisition
Licensing: Not available
Regulatory Approval
Executive Changes: Not available

Structured Data:

Company Name: Bristol-Myers Squibb Co.
Ticker Symbol: BMYMP

Abiopharma

Bristol-Myers Squibb Co. (BMYMP)

📋 Bristol-Myers Squibb Co. (BMYMP) - Clinical Trial Update

Event Details:

🔬 Clinical Development Pipeline (Bristol-Myers Squibb Co.):

💼 Business Developments:

Structured Data:

Search

News categories

News list

Bristol-Myers Squibb Co. (BMYMP)

📋 Bristol-Myers Squibb Co. (BMYMP) - Clinical Trial Update

Event Details:

🔬 Clinical Development Pipeline (Bristol-Myers Squibb Co.):

💼 Business Developments:

Structured Data:

Search

News categories